The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET mAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC).
 
Julie Bauman
Consulting or Advisory Role - AVEO (Inst); BlueDot (Inst); Johnson & Johnson/Janssen
Research Funding - AstraZeneca (Inst); AVEO (Inst); BioNTech SE (Inst); Celldex (Inst); CUE Biopharma (Inst); Moderna Therapeutics (Inst)
 
Lisa Licitra
Honoraria - ALTIS Omnia Pharma Service Srl; Bristol Mayers Squibb [K.K.]; Merck KGaA; Merck Serono; MSD IT
Consulting or Advisory Role - Abbvie S.r.l.; Alentis Therapeutics; AVEO; BeOne Medicines Italy S.r.l.; Bicara Therapeutics; Genmab; GlaxoSmithKline; GlaxoSmithKline AG Zweigniederlassung Baar/Zug; Janssen; Janssen Cilag S.p.A.; Janssen Cilag S.p.A.; Janssen Research & Development; Leo Pharma A/S; MedImmune; Merck Healtcare KGaA; Merck Serono; MSD; Pfizer; Purple Biotech; Purple Biotech, Ltd; Regeneron; Roche; Simon-Kucher and Partners Italia S.r.l.; Takeda Pharmaceuticals USA, Inc; Urogen pharma
Research Funding - Adlai Nortye (Inst); Alentis Therapeutics (Inst); Ascendis Pharma Oncology Division A/S (Inst); AstraZeneca (Inst); AVEO Pharmaceuticals, Inc (Inst); BeiGene (Inst); Exelixis (Inst); Genmab (Inst); Gilead Sciences (Inst); Incyte (Inst); InhibRx Biosciences (Inst); ISA Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Merck Sharp&Dome Corp (Inst); Merus NV (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sciences, Inc (Inst); Sun Pharmaceutica (Inst); Syneos Health (Inst)
Travel, Accommodations, Expenses - TAE Life Sciences
 
Bhumsuk Keam
Honoraria - MSD Oncology
Consulting or Advisory Role - AVEO; Bicara Therapeutics; Handok; TiumBio; Trial Informatics; Yuhan
Research Funding - AstraZeneca; Bayer
 
Neal Akhave
Honoraria - American Society of Clinical Oncology; ASCO
Consulting or Advisory Role - Adcendo; Genmab/Seagen
Research Funding - AVEO (Inst); Bicara Therapeutics (Inst); Innocare (Inst); Merus (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology; American Society of Clinical Oncology; Genmab/Seagen
 
Muh-Hwa Yang
No Relationships to Disclose
 
Kevin Harrington
Honoraria - Abbvie (Inst); ALX Oncology (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Flamingo Pharma (Inst); GlaxoSmithKline (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); Merus (Inst); MSD (Inst); Nanobiotix (Inst); PDS Biotechnology (Inst); PsiVac Ltd (Inst); QBiotics (Inst); Replimune (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Onchilles Pharma (Inst); Replimune (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Christine Chung
Consulting or Advisory Role - AVEO; Bicara Therapeutics; Johnson & Johnson/Janssen; Regeneron
Research Funding - Acrivon Therapeutics (Inst); Regeneron (Inst)
 
Sébastien Salas
No Relationships to Disclose
 
Aurora Mirabile
Consulting or Advisory Role - Eisai
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Jessica Bauman
Consulting or Advisory Role - AVEO; Delcath Systems (I); Innovent Biologics; J & J; Merus; Pfizer
Travel, Accommodations, Expenses - Delcath Systems (I); Merus
 
Nabil Saba
Employment - Winship Cancer Institute
Honoraria - BMS; Coherus Biosciences; Exelixis; GlaxoSmithKline; Johnson & Johnson/Janssen; Medscape; Merck; Nanobiotix; Reddy Pharma Iberia; Summit Therapeutics; Surface Oncology
Consulting or Advisory Role - Akeso Biopharma
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Deborah Wong
Honoraria - Bicara Therapeutics
Consulting or Advisory Role - Bicara Therapeutics; Coherus Biosciences; Fennec Pharma; Merck; Merus; RAPT Therapeutics
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bicara Therapeutics (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Johnson & Johnson/Janssen (Inst); Lilly; Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pyxis (Inst); Regeneron (Inst); Sensei Biotherapeutics (Inst); Tempus (Inst); TopAlliance BioSciences Inc (Inst)
Travel, Accommodations, Expenses - Bicara Therapeutics; Merus; Regeneron
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
 
Suzy Muggeo
Employment - AVEO
 
Bo Jin
Employment - AVEO; Sinocelltech Group Limited
Stock and Other Ownership Interests - Sinocelltech Group Limited
 
Paulina Cox
Employment - AVEO Pharmaceuticals Inc.
 
Edgar Braendle
Employment - AVEO
 
Robert Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Stock and Other Ownership Interests - tosk
Consulting or Advisory Role - Abbvie; Abbvie; ALX Oncology; Astellas Pharma; AstraZeneca; aveo; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Eisai; EMD Serono; Genmab; Genzyme; GlaxoSmithKline; Johnson & Johnson/Janssen; Merck; PDS Biotechnology; RAPT Therapeutics; Scholar Rock
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst); Merus (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Boehringer Ingelheim; Hookipa Pharma; Incyte; ISA Pharmaceuticals; Nanobiotix